Cogent Biosciences, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC COGT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

164,140

Value ($000)

5,830

Weight

0.0%

2022 Q4 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,830	0.0%	164,140	12/31/2025
2025 Q3	11/14/2025	2,053	0.0%	142,954	9/30/2025
2025 Q2	8/14/2025	1,488	0.0%	207,198	6/30/2025
2025 Q1	5/19/2025	888	0.0%	148,280	3/31/2025
2024 Q4	2/14/2025	1,058	0.0%	135,604	12/31/2024
2024 Q3	11/14/2024	1,273	0.0%	117,863	9/30/2024
2024 Q2	8/14/2024	1,064	0.0%	126,217	6/30/2024
2024 Q1	5/15/2024	467	0.0%	69,557	3/31/2024
2023 Q4	2/14/2024	350	0.0%	59,557	12/31/2023
2023 Q3	11/13/2023	504	0.0%	51,657	9/30/2023
2023 Q2	8/11/2023	240	0.0%	22,200	6/30/2023
2023 Q1	5/15/2023	240	0.0%	22,200	3/31/2023
2022 Q4	2/14/2023	257	0.0%	22,200	12/31/2022